Business

The Australian company offers its members access to AI agents that analyze their health data, lifelong health plans, whole-body testing and a personal doctor.

The funds will be used to grow the company's engineering and commercial workforce, enhance product development, and accelerate integration with payers and providers.

The company will utilize the funds to accelerate the development of its clinical diagnostic platform and expand its partnerships with pharmaceutical and biotechnology firms.

The company offers mail-in semen analysis and vasectomy testing.

Patients can get more access to their healthcare information when AI is used to translate patient notes in their chart into a patient-friendly language and format, says Dr. Jonah Zaretsky, medical director at NYU Langone Hospital Brooklyn.

Artificial intelligence gives Cedars-Sinai's clinicians EHR-supported diagnoses and treatment plan recommendations after patients complete virtual urgent care clinic intake questions in a structured chat.

The new firm will offer partners an expanded range of methods and workflows for small-molecule and peptide drug discovery.

AI can be used as a tool to provide patients and their families with more information, faster access and more affordable care, says Laura Cooley, editor in chief of the Journal of Patient Experience.

The company will use the funds to augment key content partnerships.

Arnaub Chatterjee, Datavant president and GM of life sciences, says the company will streamline data linking and evidence generation across real-world and clinical trial data.